Attitudinal Barriers to Analgesic Use among Patients with Substance Use Disorders
Table 3
Logistic regression models of moderate-to-significant barriers stratified by substance use disorder†* ().
Side Effect
Addiction
Reporting Pain
OR (95% CI)
P value
OR (95% CI)
P value
OR (95% CI)
P value
Unadjusted
OUD versus No SUD
2.09 (1.37, 3.20)
<0.001
2.78 (1.54, 5.00)
<0.001
0.83 (0.53, 1.29)
0.41
Nonopioid SUD versus no SUD
1.49 (0.97, 2.29)
0.07
1.20 (0.73, 1.97)
0.48
0.49 (0.29, 0.83)
0.01
OUD versus nonopioid SUD
1.40 (0.83, 2.37)
0.21
2.32 (1.16, 4.62)
0.02
1.69 (0.93, 3.10)
0.09
Adjusted
OUD versus no SUD
2.30 (1.44, 3.68)
<0.001
2.69 (1.44, 5.03)
0.002
0.82 (0.50, 1.35)
0.44
Non opioid SUD versus no SUD
1.64 (1.02, 2.65)
0.04
1.27 (0.74, 2.19)
0.39
0.43 (0.24, 0.76)
0.004
OUD versus nonopioid SUD
1.40 (0.81, 2.43)
0.23
2.12 (1.04, 4.30)
0.04
1.91 (1.01, 3.60)
0.045
†Moderate-to-significant barriers defined as score of ≥3 on subscale (range 0–5).
*Models adjusted for gender, employment, depression, somatic symptom severity, education, race, PTSD, and recent opioid use.
